small intestine cancer (Cancer)
Information
- Disease name
- small intestine cancer
- Disease ID
- DOID:10154
- Description
- "An intestinal cancer that is located_in the small intestine." [url:http\://en.wikipedia.org/wiki/Small_intestine]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03345563 | Active, not recruiting | N/A | Project HERO: Health Empowerment & Recovery Outcomes | July 19, 2019 | December 31, 2030 |
| NCT00003368 | Completed | Phase 1 | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis | June 1998 | July 2006 |
| NCT00003427 | Completed | Phase 1 | Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | April 1998 | April 2002 |
| NCT00003600 | Completed | Phase 3 | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | December 1998 | January 2010 |
| NCT00003687 | Completed | Phase 3 | Treatment for Chronic Pain in Patients With Advanced Cancer | June 11, 1998 | February 10, 2009 |
| NCT00003939 | Completed | Phase 2 | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma | ||
| NCT00003993 | Completed | Phase 1 | Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma | September 1999 | |
| NCT00004002 | Completed | Phase 1 | PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma | July 1999 | |
| NCT00004066 | Completed | Phase 2 | Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma | June 1999 | October 2003 |
| NCT00004189 | Completed | Phase 1 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | October 1999 | |
| NCT00004258 | Completed | Phase 1 | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer | December 1999 | September 2001 |
| NCT00004895 | Completed | Phase 2 | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | October 1999 | October 2002 |
| NCT00004904 | Completed | Phase 1 | Stem Cell Transplantation in Treating Patients With Hematologic Cancer | October 1999 | July 2000 |
| NCT00004910 | Completed | Phase 1/Phase 2 | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | January 2000 | February 2003 |
| NCT00004911 | Completed | Phase 1/Phase 2 | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | January 2000 | February 2003 |
| NCT00005021 | Completed | Phase 1 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | July 1996 | May 2003 |
| NCT00005049 | Completed | Phase 2 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | May 1997 | |
| NCT00005590 | Completed | Phase 3 | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma | August 1999 | September 2005 |
| NCT00005634 | Completed | Phase 1 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | January 2000 | October 2002 |
| NCT00005639 | Completed | Phase 1 | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment | March 2000 | July 2005 |
| NCT00005804 | Completed | Phase 2 | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | October 1999 | August 2002 |
| NCT00005874 | Completed | Phase 2 | Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas | June 1999 | April 2004 |
| NCT00006009 | Completed | Phase 1 | Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma | April 2001 | October 2003 |
| NCT00006039 | Completed | Phase 2 | Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma | December 1999 | March 2001 |
| NCT00006221 | Completed | Phase 1 | BMS-247550 in Treating Patients With Advanced Cancers | November 2000 | |
| NCT00006340 | Completed | Phase 1 | Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus | December 1994 | July 2000 |
| NCT00006348 | Completed | Phase 3 | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | October 2000 | September 2001 |
| NCT00006357 | Completed | Phase 1/Phase 2 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | August 2000 | |
| NCT00006379 | Completed | Phase 2 | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA | June 2000 | October 2011 |
| NCT00654160 | Completed | Phase 1 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | June 2008 | December 3, 2012 |
| NCT00445965 | Completed | Phase 2 | Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer | January 2006 | February 1, 2023 |
| NCT00474994 | Completed | Phase 2 | Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas | April 2007 | November 2010 |
| NCT00489515 | Completed | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | February 1999 | August 2010 | |
| NCT00544193 | Completed | Phase 1 | Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | December 1997 | August 2012 |
| NCT00561418 | Completed | Phase 1 | Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma | November 2007 | May 2013 |
| NCT00562380 | Completed | Phase 1 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | October 2005 | June 2010 |
| NCT00569309 | Completed | N/A | Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma | December 12, 2007 | July 29, 2011 |
| NCT00589563 | Completed | Phase 2 | Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer | May 2007 | February 2012 |
| NCT00646139 | Completed | Phase 1 | KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment | October 2007 | March 2009 |
| NCT00002759 | Completed | Phase 1 | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma | June 1996 | |
| NCT00734890 | Completed | Phase 1 | Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma | March 2008 | February 2011 |
| NCT00836992 | Completed | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | January 2009 | July 27, 2015 | |
| NCT00897923 | Completed | Imaging of Radiolabeled White Blood Cells in Patients With Non-Hodgkin's Lymphoma | September 2003 | February 10, 2012 | |
| NCT00956475 | Completed | Quality of Life in Younger Leukemia and Lymphoma Survivors | October 2008 | August 2011 | |
| NCT00987766 | Completed | Phase 1 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | November 2009 | October 2016 |
| NCT01273090 | Completed | Phase 1 | Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma | May 2011 | October 2013 |
| NCT02489422 | Completed | N/A | Programs To Support You During Chemotherapy | August 2016 | January 2020 |
| NCT04476082 | Completed | Nutrition in Gastrointestinal Tumors | June 25, 2020 | December 6, 2022 | |
| NCT00016172 | Completed | Phase 1 | ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma | November 2000 | April 2002 |
| NCT00019019 | Completed | Phase 1 | Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas | October 1994 | July 2006 |
| NCT00019344 | Completed | Phase 1 | Flavopiridol in Treating Patients With Refractory Cancer | August 1997 | |
| NCT00019474 | Completed | Phase 2 | Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | March 1998 | August 2000 |
| NCT00019513 | Completed | Phase 1 | Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas | August 1998 | June 2004 |
| NCT00019773 | Completed | Phase 1 | Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer | July 1999 | |
| NCT00025129 | Completed | Phase 1 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | March 2001 | May 2004 |
| NCT00025441 | Completed | Phase 2 | Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors | November 1998 | March 2010 |
| NCT00031941 | Completed | Phase 1 | CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy | April 2002 | April 2009 |
| NCT00036790 | Completed | Phase 1 | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer | February 2002 | |
| NCT00042900 | Completed | Phase 1 | Pyroxamide in Treating Patients With Advanced Cancer | April 2002 | September 2002 |
| NCT00049400 | Completed | Phase 1 | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | October 2003 | December 2007 |
| NCT00049699 | Completed | Phase 1 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | October 2002 | January 2008 |
| NCT00049712 | Completed | Phase 1 | Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma | October 2002 | February 2006 |
| NCT00079261 | Completed | Phase 2 | Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin's Lymphoma | January 2004 | |
| NCT00088868 | Completed | Phase 1 | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma | June 2004 | December 2010 |
| NCT00416351 | Completed | Phase 1/Phase 2 | Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment | June 27, 2006 | March 1, 2021 |
| NCT05450393 | Not yet recruiting | Data Collection of PillCamTM SB3 Capsule Endoscopy and Device-Assisted Enteroscopy Routine Care Procedures (GPS Study) | May 1, 2024 | April 30, 2026 | |
| NCT03771508 | Recruiting | Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA) | December 13, 2018 | December 30, 2025 | |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT04907643 | Recruiting | N/A | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | October 5, 2021 | March 2026 |
| NCT00012246 | Terminated | Phase 2 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | July 2002 | July 2006 |
| NCT00903396 | Terminated | Phase 2 | Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | September 2009 | May 2013 |
| NCT00003522 | Terminated | Phase 2 | Antineoplaston Therapy in Treating Patients With Cancer of the Small Intestine | August 13, 1997 | December 14, 1997 |
| NCT00896467 | Terminated | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | September 2007 | November 2010 | |
| NCT00899132 | Terminated | Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer | February 2007 | September 2012 | |
| NCT00669812 | Unknown status | Phase 2 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | February 2008 | |
| NCT00410462 | Unknown status | Phase 2 | Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma | October 2006 | |
| NCT00445497 | Unknown status | Phase 3 | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia | July 2007 | |
| NCT00562068 | Unknown status | Phase 1 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma | May 2007 | |
| NCT03958188 | Unknown status | PreOPerative Imaging of NeuroEndocrine Tumors | March 31, 2019 | December 31, 2019 | |
| NCT02325232 | Unknown status | N/A | Enteroscopy for Early Diagnosis of Tumors in Celiac Disease | February 2012 | November 2017 |
| NCT05471401 | Withdrawn | N/A | GI Organ Tracking Via Balloon Applicators | April 25, 2023 | May 31, 2025 |
| NCT00026468 | Withdrawn | Phase 2/Phase 3 | Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis | July 1999 | July 1999 |
| NCT00621036 | Withdrawn | Phase 2 | Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma | October 19, 2007 | December 8, 2008 |
- Disase is a (Disease Ontology)
- DOID:10155
- Cross Reference ID (Disease Ontology)
- GARD:9385
- Cross Reference ID (Disease Ontology)
- ICD10CM:C17
- Cross Reference ID (Disease Ontology)
- ICD9CM:152.9
- Cross Reference ID (Disease Ontology)
- NCI:C7523
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:363509000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0153425